 | • レポートコード：MRC2-11QY08409 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経口固形投与製剤のグローバル市場について調査・分析したレポートです。種類別（即時リリース、延長リリース、その他）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経口固形投与製剤の競争状況、市場シェア ・世界の経口固形投与製剤市場：種類別市場規模 2015年-2020年（即時リリース、延長リリース、その他） ・世界の経口固形投与製剤市場：種類別市場規模予測 2021年-2026年（即時リリース、延長リリース、その他） ・世界の経口固形投与製剤市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、その他） ・世界の経口固形投与製剤市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、その他） ・北米の経口固形投与製剤市場分析：米国、カナダ ・ヨーロッパの経口固形投与製剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経口固形投与製剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経口固形投与製剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経口固形投与製剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Gilead、Merck、Novartis、Pfizer、AbbVie、Boehringer Ingelheim ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
Market Analysis and Insights: Global Oral Solid Dosage Pharmaceutical Formulation Market
The global Oral Solid Dosage Pharmaceutical Formulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oral Solid Dosage Pharmaceutical Formulation Scope and Market Size
Oral Solid Dosage Pharmaceutical Formulation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Pharmaceutical Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Solid Dosage Pharmaceutical Formulation market is segmented into
Immediate Release
Extended Release
Others
Segment by Application, the Oral Solid Dosage Pharmaceutical Formulation market is segmented into
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others
Regional and Country-level Analysis
The Oral Solid Dosage Pharmaceutical Formulation market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Solid Dosage Pharmaceutical Formulation market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis
Oral Solid Dosage Pharmaceutical Formulation market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Solid Dosage Pharmaceutical Formulation business, the date to enter into the Oral Solid Dosage Pharmaceutical Formulation market, Oral Solid Dosage Pharmaceutical Formulation product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim
1 Study Coverage
1.1 Oral Solid Dosage Pharmaceutical Formulation Product Introduction
1.2 Market Segments
1.3 Key Oral Solid Dosage Pharmaceutical Formulation Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type
1.4.2 Immediate Release
1.4.3 Extended Release
1.4.4 Others
1.5 Market by Application
1.5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Drug Stores
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size, Estimates and Forecasts
2.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue 2015-2026
2.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales 2015-2026
2.2 Global Oral Solid Dosage Pharmaceutical Formulation, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Solid Dosage Pharmaceutical Formulation Competitor Landscape by Players
3.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers
3.1.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers (2015-2020)
3.1.2 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers
3.2.1 Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers (2015-2020)
3.2.2 Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2019
3.2.5 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Solid Dosage Pharmaceutical Formulation Price by Manufacturers
3.4 Oral Solid Dosage Pharmaceutical Formulation Manufacturing Base Distribution, Product Types
3.4.1 Oral Solid Dosage Pharmaceutical Formulation Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Solid Dosage Pharmaceutical Formulation Product Type
3.4.3 Date of International Manufacturers Enter into Oral Solid Dosage Pharmaceutical Formulation Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2015-2020)
4.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020)
4.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2015-2020)
4.1.3 Oral Solid Dosage Pharmaceutical Formulation Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Type (2021-2026)
4.2.3 Oral Solid Dosage Pharmaceutical Formulation Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2015-2020)
5.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020)
5.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Application (2015-2020)
5.1.3 Oral Solid Dosage Pharmaceutical Formulation Price by Application (2015-2020)
5.2 Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Solid Dosage Pharmaceutical Formulation Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Solid Dosage Pharmaceutical Formulation by Country
6.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales by Country
6.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Type
6.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Solid Dosage Pharmaceutical Formulation by Country
7.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Country
7.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Type
7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation by Region
8.1.1 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Region
8.1.2 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Type
8.3 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Solid Dosage Pharmaceutical Formulation by Country
9.1.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Sales by Country
9.1.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Type
9.3 Central & South America Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by Country
10.1.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Country
10.1.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Type
10.3 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description and Business Overview
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.2.5 Bristol-Myers Squibb Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Gilead
11.4.1 Gilead Corporation Information
11.4.2 Gilead Description and Business Overview
11.4.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Gilead Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.4.5 Gilead Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.5.5 Merck Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.6.5 Novartis Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description and Business Overview
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.7.5 Pfizer Related Developments
11.8 AbbVie
11.8.1 AbbVie Corporation Information
11.8.2 AbbVie Description and Business Overview
11.8.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AbbVie Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.8.5 AbbVie Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description and Business Overview
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.9.5 Boehringer Ingelheim Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Products Offered
11.1.5 AstraZeneca Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Solid Dosage Pharmaceutical Formulation Market Estimates and Projections by Region
12.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Regions 2021-2026
12.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast (2021-2026)
12.2.1 North America: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast (2021-2026)
12.2.2 North America: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast (2021-2026)
12.2.3 North America: Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast (2021-2026)
12.3.2 Europe: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Solid Dosage Pharmaceutical Formulation Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Solid Dosage Pharmaceutical Formulation Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Solid Dosage Pharmaceutical Formulation Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oral Solid Dosage Pharmaceutical Formulation Market Segments
Table 2. Ranking of Global Top Oral Solid Dosage Pharmaceutical Formulation Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Immediate Release
Table 5. Major Manufacturers of Extended Release
Table 6. Major Manufacturers of Others
Table 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Regions 2015-2020 (K Units)
Table 10. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Regions (2015-2020)
Table 11. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Manufacturers (2015-2020)
Table 14. Global Oral Solid Dosage Pharmaceutical Formulation Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Oral Solid Dosage Pharmaceutical Formulation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2019)
Table 16. Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Oral Solid Dosage Pharmaceutical Formulation Price (2015-2020) (USD/Unit)
Table 19. Oral Solid Dosage Pharmaceutical Formulation Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Oral Solid Dosage Pharmaceutical Formulation Product Type
Table 21. Date of International Manufacturers Enter into Oral Solid Dosage Pharmaceutical Formulation Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020) (K Units)
Table 24. Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Type (2015-2020)
Table 25. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2015-2020)
Table 27. Oral Solid Dosage Pharmaceutical Formulation Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020) (K Units)
Table 29. Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Application (2015-2020)
Table 30. North America Oral Solid Dosage Pharmaceutical Formulation Sales by Country (2015-2020) (K Units)
Table 31. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country (2015-2020)
Table 32. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2015-2020)
Table 34. North America Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020) (K Units)
Table 35. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2015-2020)
Table 36. North America Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020) (K Units)
Table 37. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2015-2020)
Table 38. Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Country (2015-2020) (K Units)
Table 39. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country (2015-2020)
Table 40. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2015-2020)
Table 42. Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020) (K Units)
Table 43. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2015-2020)
Table 44. Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020) (K Units)
Table 45. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2015-2020)
Table 54. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales by Country (2015-2020) (K Units)
Table 55. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2015-2020)
Table 58. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020) (K Units)
Table 59. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2015-2020)
Table 60. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020) (K Units)
Table 61. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2015-2020)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Major Businesses
Table 72. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. AstraZeneca Product
Table 74. AstraZeneca Recent Development
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Major Businesses
Table 77. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Recent Development
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Major Businesses
Table 82. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eli Lilly Product
Table 84. Eli Lilly Recent Development
Table 85. Gilead Corporation Information
Table 86. Gilead Description and Major Businesses
Table 87. Gilead Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Gilead Product
Table 89. Gilead Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Major Businesses
Table 92. Merck Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck Product
Table 94. Merck Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Major Businesses
Table 97. Novartis Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Major Businesses
Table 102. Pfizer Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pfizer Product
Table 104. Pfizer Recent Development
Table 105. AbbVie Corporation Information
Table 106. AbbVie Description and Major Businesses
Table 107. AbbVie Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. AbbVie Product
Table 109. AbbVie Recent Development
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Major Businesses
Table 112. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Boehringer Ingelheim Product
Table 114. Boehringer Ingelheim Recent Development
Table 115. Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Regions (2021-2026) (K Units)
Table 116. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Country (2021-2026) (K Units)
Table 120. North America: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Country (2021-2026) (K Units)
Table 122. Europe: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Region (2021-2026) (K Units)
Table 124. Asia Pacific: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Country (2021-2026) (K Units)
Table 126. Latin America: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Country (2021-2026) (K Units)
Table 128. Middle East and Africa: Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Oral Solid Dosage Pharmaceutical Formulation Players
Table 133. Oral Solid Dosage Pharmaceutical Formulation Customers List
Table 134. Oral Solid Dosage Pharmaceutical Formulation Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Solid Dosage Pharmaceutical Formulation Product Picture
Figure 2. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type in 2020 & 2026
Figure 3. Immediate Release Product Picture
Figure 4. Extended Release Product Picture
Figure 5. Others Product Picture
Figure 6. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Drug Stores
Figure 10. Others
Figure 11. Oral Solid Dosage Pharmaceutical Formulation Report Years Considered
Figure 12. Global Oral Solid Dosage Pharmaceutical Formulation Market Size 2015-2026 (US$ Million)
Figure 13. Global Oral Solid Dosage Pharmaceutical Formulation Sales 2015-2026 (K Units)
Figure 14. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Region (2015-2020)
Figure 16. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Region in 2019
Figure 17. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region (2015-2020)
Figure 18. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region in 2019
Figure 19. Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2019
Figure 21. Oral Solid Dosage Pharmaceutical Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type (2015-2020)
Figure 23. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Type in 2019
Figure 24. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2015-2020)
Figure 25. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type in 2019
Figure 26. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Price Range (2015-2020)
Figure 27. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2015-2020)
Figure 28. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application in 2019
Figure 29. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2015-2020)
Figure 30. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application in 2019
Figure 31. North America Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country in 2019
Figure 34. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country in 2019
Figure 35. U.S. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type in 2019
Figure 40. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application in 2019
Figure 41. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country in 2019
Figure 44. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country in 2019
Figure 45. Germany Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Type in 2019
Figure 56. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Application in 2019
Figure 57. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Region in 2019
Figure 60. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region in 2019
Figure 61. China Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Type in 2019
Figure 84. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Application in 2019
Figure 85. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country in 2019
Figure 88. Latin America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country in 2019
Figure 89. Mexico Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type in 2019
Figure 96. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application in 2019
Figure 97. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Country in 2019
Figure 101. Turkey Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Type in 2019
Figure 108. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Application in 2019
Figure 109. North America Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
経口固形剤形（OSDF）・医薬品添加剤の世界市場（～2026年） Market Analysis and Insights: Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market The global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Oral Soli…- 徐放性経口用ドラッグデリバリー技術の世界市場（～2026年） The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes.…
- 注射可能ドラッグデリバリー製剤の世界市場（～2026年） Market Analysis and Insights: Global Injectable Drug Delivery Formulation Market The global Injectable Drug Delivery Formulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Injectable Drug Delivery Formulation Scop…
- 口腔がん治療の世界市場（～2026年） Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…
- OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…